About Batavia Pharma
Batavia Pharma is a company. Batavia Pharma offers products and services including Generic Pharmaceuticals and R&D Services.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Batavia Pharma Pvt. Ltd
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$623.63 K (USD)31.48as on Mar 31, 2023
-
Net Profit
$100.56 K (USD)417.56as on Mar 31, 2023
-
EBITDA
$178.21 K (USD)171.19as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Batavia Pharma
Batavia Pharma offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and R&D Services.
Generic and value-added drugs are developed and manufactured to address patient needs in various markets
In-house research and development services are provided to innovate and create solutions for healthcare challenges
Funding Insights of Batavia Pharma
Detailed funding history for Batavia Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Batavia Pharma
Investment portfolio details for Batavia Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Batavia Pharma
Detailed financials for Batavia Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Batavia Pharma Comparisons
Peer comparison for Batavia Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Batavia Pharma
Detailed competitors of Batavia Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Batavia Pharma
Complete news archive for Batavia Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Batavia Pharma
Annual revenue of Batavia Pharma is $623.63K as on Mar 31, 2023.
Batavia Pharma was founded in 1985 and is recognized for its dedication to the development and manufacturing of high quality generics and value-added pharmaceutical products. A focus is placed on reducing unmet patient needs through consistent availability of medicines in Europe, the US, and other markets. Quality standards are upheld across operations, while innovation is fostered to address healthcare gaps. Consistency and dynamism are emphasized to ensure reliable delivery and adaptation to evolving needs, contributing to better global patient outcomes.
Batavia Pharma offers Generic Pharmaceuticals and R&D Services.